BCAA Supplementation for Concussion

Status Completed

Clinical Trial Summary

This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAA's) in the treatment of concussion. The aim of the study is to determine whether, compared to placebo treatment, administration of BCAA's, at one or more doses, after a concussion improves neurocognitive recovery at one or more time-periods post concussion.

Clinical Trial Description

Annually, between 100,000 to 140,000 children present to the emergency department for concussion in the United States.1 The Centers for Disease Control now estimates that 1.6 - 3.8 million sports related concussions occur each year in the United States. A large proportion of these patients have enduring cognitive and neurobehavioral problems. Concussion is a heterogeneous insult to the brain that precipitates a complex pathophysiological process that can result in a cascade of deleterious side effects. At present, there are no proven therapies to mitigate or prevent the neurocognitive and neurobehavioral consequences of concussions. The limbic hippocampus, a brain structure crucial for learning and memory, is often damaged in concussion. In preclinical studies in our laboratory, analysis of ipsilateral hippocampi isolated from mice after traumatic brain injury (TBI) demonstrated that only the concentrations of the three BCAA's (valine, isoleucine, and leucine) were significantly altered (reduced) after injury. When these brain-injured animals received dietary supplementation with BCAA's, the concentrations of these amino acids were restored in the injured hippocampus and the injured animals demonstrated significant cognitive improvement to levels comparable to those obtained in non-injured control animals. In light of these results and the increasing awareness and morbidity associated with concussion, we are proposing a pilot therapeutic exploratory clinical trial to determine the effects of BCAA's in reducing the neurocognitive side effects of concussion injury. ;

Study Design

Related Conditions & MeSH terms

Brain Concussion

Clinical Trial Details

NCT number	NCT01860404
Study type	Interventional
Source	Children's Hospital of Philadelphia
Contact
Status	Completed
Phase	Phase 2
Start date	January 2014
Completion date	January 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02299128` - Effectiveness of Early Physical Therapy Intervention for Patients With Dizziness After a Sports-Related Concussion	N/A
Completed	`NCT02383472` - LED Therapy for the Treatment of Concussive Brain Injury	N/A
Recruiting	`NCT06112093` - Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches	N/A
Terminated	`NCT02597504` - Development of a Neurocognitive Screening Test	N/A
Completed	`NCT00409058` - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI	N/A
Completed	`NCT00295074` - The Effect of Mild Traumatic Brain Injury on Recovery From Injury	N/A
Completed	`NCT00483444` - Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury	N/A
Completed	`NCT03319966` - Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
Completed	`NCT04681742` - Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome	N/A
Completed	`NCT03759223` - Enhanced Problem-Solving Training	N/A
Completed	`NCT00857207` - Metacognitive Training to Enhance Strategy Use in Blast-Related TBI	N/A
Not yet recruiting	`NCT06131242` - The s100β Levels in Patients With Mild Brain Injury.
Completed	`NCT02368366` - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI	N/A
Completed	`NCT02858544` - Concussion in Motor Vehicle Accidents: The Concussion Identification Index	N/A
Completed	`NCT00142090` - Use of Salt-Water Solution to Improve Symptoms in Concussion	N/A
Recruiting	`NCT05837676` - Problem-Solving Training for Concussion	N/A
Recruiting	`NCT06015451` - Exercise in Postconcussion Symptoms and Posttraumatic Headache	N/A
Completed	`NCT00724607` - Brain Injury Outcomes (BIO) Study
Completed	`NCT02486003` - Testing mTBI in Athletes	N/A
Unknown status	`NCT02699359` - Indirect Intracranial Pressure Measurement in Patients With Suspected or Documented Concussion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

BCAA Supplementation for Concussion — HIT_HEADS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms